Lumipulse® G SARS-CoV-2 N-IgG Controls

For in vitro diagnostic (IVD) use as quality controls, to monitor the precision and accuracy of the Lumipulse G SARS-CoV-2 N-IgG assay on the automated LUMIPULSE G System. The assay using this control is performed to quantitatively measure IgG antibodies to SARS-CoV-2 nucleocapsid (N) protein in human serum or plasma and is intended to be used in the assessment of the immune response to the SARS-CoV-2 N protein.

CE marked
Lumipulse® G SARS-CoV-2 N-IgG Controls

Product number 232354

2 x 2 Concentrations

Click here to navigate

  • Contact sales for information
  • Conditions of sale
  • Documentation
  • Insights
  • Related products
  • Product inquiry

Choose your country or region

Once you have made this selection we will show you only the content that is relevant for your country. You can change this setting any time by clicking on the flag in the top toolbar of our website and choosing another country.